Immunohistochemistry Any 3 Markers Without Interpretation in UAE | 650 AED

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing and digital imaging validation.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval from your referring hospital or pathology archive – temperature-controlled chain of custody for FFPE blocks.
Clinical Guidance: Telephonic post-test clinical guidance to support result interpretation by your oncology team.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

Immunohistochemistry (IHC) Any 3 Markers Without Interpretation is a tissue-based immunostaining panel that detects three specific cancer biomarkers to classify tumor subtypes and guide oncotherapy. The test delivers quantitative staining data without a pathologist’s diagnostic report, empowering your oncology team to make precise treatment decisions based on raw biomarker expression profiles.

Feature	Our Test (DHA-Validated)	Closest Alternative
Methodology	Fully Automated IHC with Digital Imaging	Manual IHC with Visual Scoring
Precision	99.9% Sensitivity, ISO 9001:2015 Certified	Varies, subjectivity in interpretation
Turnaround Time	5 Days (FFPE Block) / 7 Days (Large Complex Tissue)	7–10 Days
Price	650 AED	800–1200 AED

Physician Insight & Safety Protocols

“IHC markers offer high-resolution protein-level data, but their clinical value emerges only when integrated with radiological findings, patient history, and performance status. A positive stain alone does not confirm malignancy subtype; I use these quantitative profiles to narrow differentials and select targeted therapy pathways. Always review the raw report with your treating oncologist.”

— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Important Clinical Advisory

Do not alter or discontinue any prescribed cancer therapy or medication without explicit consultation with your treating physician. This IHC panel provides biomarker expression data intended to support, not replace, comprehensive clinical judgment and multidisciplinary tumor board review.

Exclusion Criteria & Safety Red Flags

Inadequate tissue specimen (insufficient tumor cells or necrotic material).
Known hypersensitivity to formaldehyde or components of the transport medium.
Active bleeding disorder or therapeutic anticoagulation not managed for biopsy (must be assessed by clinician).
If you experience sudden severe pain, pus, or uncontrolled bleeding at the biopsy site, seek emergency medical attention immediately.

Patient FAQ & Clinical Guidance

1. What does “Any 3 Markers Without Interpretation” actually mean?

This panel stains three cancer-associated proteins on your tissue sample using immunohistochemistry and provides raw staining intensity results without a pathologist’s written interpretation, leaving the clinical correlation entirely to your oncologist. Without interpretation, the report does not include a diagnosis; your doctor integrates these markers with other data to determine malignancy subtype and treatment options.

2. How should I prepare for the tissue biopsy required for this test?

Fast for at least six hours if sedation is required, inform your doctor of all blood thinners and supplements, and provide a detailed clinical history including prior cancer diagnoses, as these factors directly influence staining reliability. Your biopsy site must be infection-free; the surgeon will give you specific pre-procedure instructions based on the location.

3. Why is the price 650 AED and what does it include?

The 650 AED fee covers laboratory processing of three IHC markers on formalin-fixed tissue, digital imaging, and quality control under ISO 9001:2015 certification, but it excludes the biopsy procedure itself and professional interpretation fees. Secure courier retrieval of your archived FFPE block from the referring facility is arranged at no extra cost.

UAE Regulatory & Data Privacy Adherence

All patient data and clinical information are processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your tissue specimen and health records are handled under strict confidentiality, encryption, and access control protocols aligned with Dubai Healthcare City data governance standards.

Clinical & Logistical Metadata

Test Name	Immunohistochemistry Any 3 Markers Without Interpretation
Price (AED)	650 AED
Turnaround Time	5 Days (FFPE Block) / 7 Days (Large Complex Tissue)
Sample Type / Matrix	Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Block or Unstained Slides – Archival Specimen
Methodology Used	Fully Automated Immunohistochemistry (IHC) with Digital Imaging and Quantitative Scoring
ICD-10-CM Code	C80.1
LOINC Code	97515-9
DHA Facility License & Laboratory Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE